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History
Awareness of the public health implications
of  Campylobacter infections has evolved over
more than a century (1). In 1886, Escherich
observed organisms resembling campylobacters
in stool samples of children with diarrhea. In
1913, McFaydean and Stockman identified
campylobacters (called related Vibrio) in fetal
tissues of aborted sheep (1). In 1957, King
described the isolation of related Vibrio from
blood samples of children with diarrhea, and in
1972, clinical microbiologists in Belgium first
isolated campylobacters from stool samples of
patients with diarrhea (1). The development of
selective growth media in the 1970s permitted
more laboratories to test stool specimens for
Campylobacter. Soon Campylobacter spp. were
established as common human pathogens.
Campylobacter  jejuni infections are now the
leading cause of bacterial gastroenteritis
reported in the United States (2). In 1996, 46% of
laboratory-confirmed cases of bacterial gastroen-
teritis reported in the Centers for Disease
Control and Prevention/U.S. Department of
Agriculture/Food and Drug Administration
Collaborating Sites Foodborne Disease Active
Surveillance Network were caused by
Campylobacter species. Campylobacteriosis was
followed in prevalence by salmonellosis (28%),
shigellosis (17%), and Escherichia coli O157
infection (5%) (Figure 1).
Disease Prevalence
In the United States, an estimated 2.1 to 2.4
million cases of human campylobacteriosis
(illnesses ranging from loose stools to dysentery)
occur each year (2). Commonly reported
symptoms of patients with laboratory-confirmed
infections (a small subset of all cases) include
diarrhea, fever, and abdominal cramping. In one
study, approximately half of the patients with
laboratory-confirmed campylobacteriosis reported
a history of bloody diarrhea (3). Less frequently,
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Figure 1. Cases of Campylobacter and other
foodborne infections by month of specimen collection;
Centers for Disease Control and Prevention/U.S.
Department of Agriculture/Food and Drug Adminis-
tration Collaborating Sites Foodborne Disease Active
Surveillance Network, 1996.
Campylobacter jejuni is the most commonly reported bacterial cause of foodborne
infection in the United States. Adding to the human and economic costs are chronic
sequelae associated with C. jejuni infection—Guillian-Barré syndrome and reactive
arthritis. In addition, an increasing proportion of human infections caused by C. jejuni are
resistant to antimicrobial therapy. Mishandling of raw poultry and consumption of
undercooked poultry are the major risk factors for human campylobacteriosis. Efforts to
prevent human illness are needed throughout each link in the food chain.29 Vol. 5, No. 1, JanuaryFebruary 1999 Emerging Infectious Diseases
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C.  jejuni infections produce bacteremia, septic
arthritis, and other extraintestinal symptoms
(4). The incidence of campylobacteriosis in
HIV-infected patients is higher than in the
general population. For example, in Los
Angeles County between 1983 and 1987, the
reported incidence of campylobacteriosis in
patients with AIDS was 519 cases per 100,000
population, 39 times higher than the rate in
the general population. (5). Common complica-
tions of campylobacteriosis in HIV-infected
patients are recurrent infection and infection
with antimicrobial-resistant strains (6). Deaths
from  C.  jejuni infection are rare and occur
primarily in infants, the elderly, and patients
with underlying illnesses (2).
Sequelae to Infection
Guillain-Barré syndrome (GBS), a
demyelating disorder resulting in acute neuro-
muscular paralysis, is a serious sequela of
Campylobacter infection (7). An estimated one
case of GBS occurs for every 1,000 cases of
campylobacteriosis (7). Up to 40% of patients
with the syndrome have evidence of recent
Campylobacter infection (7). Approximately 20%
of patients with GBS are left with some
disability, and approximately 5% die despite
advances in respiratory care. Campylobacteriosis
is also associated with Reiter syndrome, a reactive
arthropathy. In approximately 1% of patients
with campylobacteriosis, the sterile postinfection
process occurs 7 to 10 days after onset of diarrhea
(8). Multiple joints can be affected, particularly
the knee joint. Pain and incapacitation can last
for months or become chronic.
Both GBS and Reiter syndrome are thought
to be autoimmune responses stimulated by
infection. Many patients with Reiter syndrome
carry the HLA B27 antigenic marker (8). The
pathogenesis of GBS (9) and Reiter syndrome is
not completely understood.
Treatment of C. jejuni Infections
Supportive measures, particularly fluid and
electrolyte replacement, are the principal
therapies for most patients with
campylobacteriosis (10). Severely dehydrated
patients should receive rapid volume expansion
with intravenous fluids. For most other patients,
oral rehydration is indicated. Although
Campylobacter infections are usually self
limiting, antibiotic therapy may be prudent for
patients who have high fever, bloody diarrhea, or
more than eight stools in 24 hours; immunosup-
pressed patients, patients with bloodstream
infections, and those whose symptoms worsen or
persist for more than 1 week from the time of
diagnosis. When indicated, antimicrobial therapy
soon after the onset of symptoms can reduce the
median duration of illness from approximately
10 days to 5 days. When treatment is delayed
(e.g., until C. jejuni infection is confirmed by a
medical laboratory), therapy may not be
successful (10). Ease of administration, lack of
serious toxicity, and high degree of efficacy make
erythromycin the drug of choice for C. jejuni
infection; however, other antimicrobial agents,
particularly the quinolones and newer macrolides
including azithromycin, are also used.
Antimicrobial Resistance
The increasing rate of human infections
caused by antimicrobial-resistant strains of C.
jejuni makes clinical management of cases of
campylobacteriosis more difficult (11,12). Anti-
microbial resistance can prolong illness and
compromise treatment of patients with bacter-
emia. The rate of antimicrobial-resistant enteric
infections is highest in the developing world,
where the use of antimicrobial drugs in humans
and animals is relatively unrestricted. A 1994
study found that most clinical isolates of C. jejuni
from U.S. troops in Thailand were resistant to
ciprofloxacin. Additionally, nearly one third of
isolates from U.S. troops located in Hat Yai were
resistant to azithromycin (11). In the industrial-
ized world, the emergence of fluoroquinolone-
resistant strains of C. jejuni illustrates the need
for prudent antimicrobial use in food-animal
production (12). Experimental evidence demon-
strates that fluoroquinolone-susceptible
C.  jejuni readily become drug-resistant in
chickens when these drugs are administered
(13). After flouroquinolone use in poultry was
approved in Europe, resistant C. jejuni strains
emerged rapidly in humans during the early
1990s (12). Similarly, within 2 years of the 1995
approval of fluoroquinolone use for poultry in the
United States, the number of domestically
acquired human cases of ciprofloxacin-resistant
campylobacteriosis doubled in Minnesota (14). In
a 1997 study conducted in Minnesota, 12 (20%) of
60 C .  jejuni isolates obtained from chicken
purchased in grocery stores were ciprofloxacin-
resistant (14).30 Emerging Infectious Diseases Vol. 5, No. 1, JanuaryFebruary 1999
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Pathogenesis
The pathogenesis of C. jejuni infection
involves both host- and pathogen-specific
factors. The health and age of the host (2) and C.
jejuni-specific humoral immunity from previous
exposure (15) influence clinical outcome after
infection. In a volunteer study, C. jejuni infection
occurred after ingestion of as few as 800
organisms (16). Rates of infection increased with
the ingested dose. Rates of illness appeared to
increase when inocula were ingested in a
suspension buffered to reduce gastric acidity (16).
Many pathogen-specific virulence determi-
nants may contribute to the pathogenesis of
C. jejuni infection, but none has a proven role
(17). Suspected determinants of pathogenicity
include chemotaxis, motility, and flagella, which
are required for attachment and colonization of
the gut epithelium (Figure 2) (17). Once
colonization occurs, other possible virulence
determinants are iron acquisition, host cell
invasion, toxin production, inflammation and
active secretion, and epithelial disruption with
leakage of serosal fluid (17).
Survival in the Environment
Survival of C. jejuni outside the gut is poor,
and replication does not occur readily (17).
C.  jejuni grows best at 37°C to 42°C (18), the
approximate body temperature of the chicken
(41°C to 42°C). C. jejuni grows best in a low
oxygen or microaerophilic environment, such as
an atmosphere of 5% O2, 10% CO2, and 85% N2.
The organism is sensitive to freezing, drying,
acidic conditions (pH £ 5.0), and salinity.
Sample Collection and Transport
If possible, stool specimens should be chilled
(not frozen) and submitted to a laboratory within
24 hours of collection. Storing specimens in deep,
airtight containers minimizes exposure to
oxygen  and desiccation. If a specimen cannot be
processed within 24 hours or is likely to contain
small numbers of organisms, a rectal swab
placed in a specimen transport medium (e.g.,
Cary-Blair) should be used. Individual laborato-
ries can provide guidance on specimen handling
procedures (18).
Numerous procedures are available for
recovering  C.  jejuni from clinical specimens (18).
Direct plating is cost-effective for testing large
numbers of specimens; however, testing sensitiv-
ity may be reduced. Preenrichment (raising the
temperature from 36°C to 42°C over several
hours), filtration, or both are used in some
laboratories to improve recovery of stressed
C.  jejuni organisms from specimens (e.g., stored
foods or swabs exposed to oxygen) (19). Isolation
can be facilitated by using selective media
containing antimicrobial agents, oxygen quench-
ing agents, or a low oxygen atmosphere, thus
decreasing the number of colonies that must be
screened (18,19).
Subtyping of Isolates
No standard subtyping technique has been
established for C. jejuni. Soon after the organism
was described, two serologic methods were
developed, the heat-stable or somatic O antigen
(20) and the heat-labile antigen schemes (21).
These typing schemes are labor intensive, and
their use is limited almost exclusively to
reference laboratories. Many different DNA-
based subtyping schemes have been developed,
including pulsed-field gel electrophoresis (PFGE)
and randomly amplified polymorphic DNA
(RAPD) analysis (22). Various typing schemes
have been developed on the basis of the sequence
of flaA, encoding flagellin (23); however, recent
evidence suggests that this locus may not be
representative of the entire genome (24).
Transmission to Humans
Most cases of human campylobacteriosis are
sporadic. Outbreaks have different epidemio-
Figure 2. Scanning electron microscope image of
Campylobacter jejuni, illustrating its corkscrew
appearance and bipolar flagella. Source: Virginia-
Maryland Regional College of Veterinary Medicine,
Blacksburg, Virginia.31 Vol. 5, No. 1, JanuaryFebruary 1999 Emerging Infectious Diseases
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logic characteristics from sporadic infections (2).
Many  outbreaks occur during the spring and
autumn (2). Consumption of raw milk was
implicated as the source of infection in 30 of the
80 outbreaks of human campylobacteriosis
reported to CDC between 1973 and 1992.
Outbreaks caused by drinking raw milk often
involve farm visits (e.g., school field trips) during
the temperate seasons. In contrast, sporadic
Campylobacter isolates peak during the summer
months (Figure 1). A series of case-control
studies identified some risk factors for sporadic
campylobacteriosis, particularly handling raw
poultry (25,26) and eating undercooked poultry
(27-31) (Table). Other risk factors accounting for
a smaller proportion of sporadic illnesses include
drinking untreated water (29); traveling abroad
(25); eating barbequed pork (28) or sausage (27);
drinking raw milk (29, 32) or milk from bird-
pecked bottles (33); and contact with dogs (27)
and cats (29,31), particularly juvenile pets or
pets with diarrhea (25,34). Person-to-person
transmission is uncommon (25,32). Overlap is
reported between serotypes of C. jejuni found in
humans, poultry, and cattle, indicating that
foods of animal origin may play a major role in
transmitting C. jejuni to humans (35).
In the United States, infants have the highest
age-specific Campylobacter isolation rate, approxi-
mately 14 per 100,000 person years. As children
get older, isolation rates decline to approximately
4 per 100,000 person years for young adolescents.
A notable feature of the epidemiology of human
campylobacteriosis is the high isolation rate among
young adults, approximately 8 per 100,000 person
years. Among middle-aged and older adults, the
isolation rate is < 3 per 100,000 person years (2).
The peak isolation rate in neonates and infants is
attributed in part to susceptibility on first exposure
and to the low threshold for seeking medical care
for infants (2). The high rate of infection during
early adulthood, which is pronounced among men,
is thought to reflect poor food-handling practices
in a population that, until recently, relied on others
to prepare meals (2).
Reservoirs
The ecology of C .  jejuni involves wildlife
reservoirs, particularly wild birds. Species that
carry C. jejuni include migratory birdscranes,
ducks, geese (36), and seagulls (37). The
organism is also found in other wild and domestic
bird species, as well as in rodents (38). Insects
can carry the organism on their exoskeleton (39).
Table. Epidemiologic studies of laboratory-confirmed cases of sporadic campylobacteriosis
Number Foods associated Animal
Cases Controls Date Population Location with illness contacts Ref.
  52 103 1989- Residents of Norway Poultry, sausage  Dogs 27
 1990    three counties
218 526 1982- HMO patients Washington Undercooked Animals with 30,34
 1983 State    chicken    diarrhea
  29   42 1990 Residents of England Bottled milka 33
   Manchester
  45   45 1983- University students Georgia Chicken Cats 31
 1984
  53 106 1982- Rural children Iowa Raw milk 32
 1983
  40   80 1981 Residents of Denver, Colorado Untreated water, Cats 29
   Ft. Collins    raw milk,
   undercooked
   chicken
  54   54 1982 Residents of Netherlands Chicken, pork, 28
   Rotterdam    barbequed foods
  10   15 1982 Residents of Colorado Preparing chicken 26
   Larimer County
  55   14 1980 Residents of Sweden Preparing chicken Kitten, dog 25
   Göteborg    with
   diarrhea
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The intestines of poultry are easily colonized
with C. jejuni. Day-old chicks can be colonized
with as few as 35 organisms (40). Most chickens
in commercial operations are colonized by 4
weeks (41,42). Vertical transmission (i.e., from
breeder flocks to progeny) has been suggested in
one study but is not widely accepted (43).
Reservoirs in the poultry environment include
beetles (39), unchlorinated drinking water (44),
and farm workers (41,42,45). Feeds are an
unlikely source of campylobacters since they are
dry and campylobacters are sensitive to drying.
C. jejuni is a commensal organism of the
intestinal tract of cattle (46). Young animals are
more often colonized than older animals, and
feedlot cattle are more likely than grazing
animals to carry campylobacters (47). In one
study, colonization of dairy herds was associated
with drinking unchlorinated water (48).
Campylobacters are found in natural water
sources throughout the year. The presence of
campylobacters is not clearly correlated with
indicator organisms for fecal contamination
(e.g.,  E.  coli)(49). In temperate regions, organism
recovery rates are highest during the cold season
(49,50). Survival in cold water is important in the
life cycle of campylobacters. In one study,
serotypes found in water were similar to those
found in humans (50). When stressed,
campylobacters enter a viable but nonculturable
state, characterized by uptake of amino acids
and maintenance of an intact outer membrane
but inability to grow on selective media; such
organisms, however, can be transmitted to
animals (51). Additionally, unchlorinated drink-
ing water can introduce campylobacters into the
farm environment (44,48).
Campylobacter in the Food Supply
C. jejuni is found in many foods of animal
origin. Surveys of raw agricultural products
support epidemiologic evidence implicating
poultry, meat, and raw milk as sources of human
infection. Most retail chicken is contaminated
with C. jejuni; one study reported an isolation
rate of 98% for retail chicken meat (52). C. jejuni
counts often exceed 103 per 100 g. Skin and
giblets have particularly high levels of contami-
nation. In one study, 12% of raw milk samples
from dairy farms in eastern Tennessee were
contaminated with C. jejuni (53). Raw milk is
presumed to be contaminated by bovine feces;
however, direct contamination of milk as a
consequence of mastitis also occurs (54).
Campylobacters are also found in red meat. In
one study, C. jejuni was present in 5% of raw
ground beef and in 40% of veal specimens (55).
Control of Campylobacter Infection
On the Farm
Control of Campylobacter contamination on
the farm may reduce contamination of carcasses,
poultry, and red meat products at the retail level
(27). Epidemiologic studies indicate that strict
hygiene reduces intestinal carriage in food-
producing animals (41,42,45). In field studies,
poultry flocks that drank chlorinated water had
lower intestinal colonization rates than poultry
that drank unchlorinated water (42,44). Experi-
mentally, treatment of chicks with commensal
bacteria (56) and immunization of older birds
(57) reduced C. jejuni colonization. Because
intestinal colonization with campylobacters
readily occurs in poultry flocks, even strict
measures may not eliminate intestinal car-
riage by food-producing animals (39,41).
At Processing
Slaughter and processing provide opportuni-
ties for reducing C. jejuni counts on food-animal
carcasses. Bacterial counts on carcasses can
increase during slaughter and processing steps.
In one study, up to a 1,000-fold increase in
bacterial counts on carcasses was reported during
transportation to slaughter (58). In studies of
chickens (59) and turkeys (60) at slaughter,
bacterial counts increased by approximately 10-
to 100-fold during defeathering and reached the
highest level after evisceration. However,
bacterial counts on carcasses decline during
other slaughter and processing steps. In one
study, forced-air chilling of swine carcasses
caused a 100-fold reduction in carcass
contamination (61). In Texas turkey plants,
scalding reduced carcass counts to near or
below detectable levels (60). Adding sodium
chloride or trisodium phosphate to the chiller
water in the presence of an electrical current
reduced  C.  jejuni contamination of chiller
water by 2 log10 units (62). In a slaughter plant
in England, use of chlorinated sprays and
maintenance of clean working surfaces resulted
in a 10- to 100-fold decrease in carcass33 Vol. 5, No. 1, JanuaryFebruary 1999 Emerging Infectious Diseases
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contamination (63). In another study, lactic
acid spraying of swine carcasses reduced counts
by at least 50% to often undetectable levels
(64). A radiation dose of 2.5 KGy reduced
C. jejuni levels on retail poultry by 10 log10
units (65).
Conclusions
C. jejuni, first identified as a human
diarrheal pathogen in 1973, is the most
frequently diagnosed bacterial cause of human
gastroenteritis in the United States. Sequelae
including GBS and reactive arthritis are
increasingly recognized, adding to the human
and economic cost of illness from human
campylobacteriosis. The emergence of
fluoroquinolone-resistant infections in Europe
and the United States, temporally associated
with the approval of fluoroquinolone use in
veterinary medicine, is also a public health
concern. The consumption of undercooked
poultry and cross-contamination of other foods
with drippings from raw poultry are leading risk
factors for human campylobacteriosis. Reinforc-
ing hygienic practices at each link in the food
chainfrom producer to consumeris critical in
preventing the disease.
Dr. Altekruse is a Public Health Service
Epidemiology Fellow with the Food and Drug
Administration, Center for Veterinary Medicine.  His
current research interest is antimicrobial-resistant
foodborne pathogens.
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